resveratrol |
501-36-0 |
trans-resveratrol |
3,4',5-Trihydroxystilbene |
(E)-5-(4-Hydroxystyryl)benzene-1,3-diol |
3,5,4'-Trihydroxystilbene |
(E)-resveratrol |
Resvida |
3,4',5-Stilbenetriol |
5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
3,4',5-Trihydroxy-trans-stilbene |
Biofort |
Cuspidatin |
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol |
SRT 501 |
SRT-501 |
(E)-5-(p-Hydroxystyryl)resorcinol |
Resveratrol p 5 |
SRT501 |
Resveratrol(e)-form |
3,5,4'-Trihydroxy-trans-stilbene |
Melinjo resveratrol 20 |
CHEBI:45713 |
Srt 501m |
trans-3,4',5-trihydroxystilbene |
5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol |
NSC 327430 |
NSC-327430 |
trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene |
CCRIS 8952 |
5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
DTXSID4031980 |
UNII-Q369O8926L |
HSDB 7571 |
Resveratrol (Standard) |
5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol |
Ca 1201 |
C14H12O3 |
1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)- |
1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]- |
BIA 6-512 |
BIA-6-512 |
NSC327430 |
CHEMBL165 |
Q369O8926L |
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol |
MLS000069735 |
133294-37-8 |
DTXCID2011980 |
CHEBI:27881 |
trans-3,4',5 - trihydroxystilbene |
MFCD00133799 |
SMR000058206 |
RESVERATROL (MART.) |
RESVERATROL [MART.] |
1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)- |
Resveratol |
TRANS-RESVERATROL (USP-RS) |
TRANS-RESVERATROL [USP-RS] |
5-((E)-2-(4-HYDROXYPHENYL)-ETHENYL) BENZENE-1,3 DIOL |
trans Resveratrol |
3,4',5-trihydroxy-stilbene |
Resveratrol, natural |
5-(2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol |
SR-01000000163 |
5-((E)-2-(4-hydroxyphenyl)vinyl)benzene-1,3-diol |
1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]- |
Jotrol |
3fts |
4jaz |
4qer |
Resveratrol, E- |
Resveratrol,(S) |
KUC104385N |
Stilbene, 2f |
TaxusChinensisiRehd |
NCGC00015894-02 |
CAS-501-36-0 |
STL |
Prestwick_619 |
Resveratrol, trans- |
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol |
KSC-10-164 |
Resveratrol, synthetic |
RM-1812 |
Opera_ID_586 |
RESVERATROL [MI] |
Prestwick2_000508 |
Prestwick3_000508 |
Spectrum5_000552 |
RESVERATROL [HSDB] |
RESVERATROL [INCI] |
R 5010 |
RESVERATROL [VANDF] |
1,3-Benzenediol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]- |
Lopac0_001111 |
REGID_for_CID_6240 |
SCHEMBL19425 |
BSPBio_000435 |
BSPBio_001114 |
BSPBio_003461 |
RESVERATROL [WHO-DD] |
MLS001055357 |
MLS001076538 |
MLS001424228 |
MLS002207121 |
MLS002222231 |
SPECTRUM1502223 |
CU-01000001503-3 |
BPBio1_000479 |
cid_445154 |
GTPL8741 |
SGCUT00007 |
Resveratrol, analytical standard |
REGID_for_CID_445154 |
BDBM23926 |
Resveratrol, >=99% (HPLC) |
AMY5760 |
2l98 |
BCPP000091 |
HMS1362H15 |
HMS1569F17 |
HMS1792H15 |
HMS1921N04 |
HMS1990H15 |
HMS2052I09 |
HMS2096F17 |
HMS2232A18 |
HMS3263O04 |
HMS3403H15 |
HMS3412O14 |
HMS3649A20 |
HMS3676O14 |
BCP01416 |
to_000079 |
Tox21_110257 |
Tox21_201374 |
Tox21_303376 |
Tox21_501111 |
AC-727 |
BBL028252 |
CCG-38874 |
HB4055 |
HY-16561R |
LMPK13090005 |
s1396 |
STL146386 |
AKOS005720936 |
Tox21_110257_1 |
CS-1050 |
DB02709 |
KS-5047 |
LP01111 |
MCULE-5678456463 |
NC00349 |
SDCCGMLS-0002998.P003 |
SDCCGSBI-0051080.P003 |
IDI1_002152 |
NCGC00017352-05 |
NCGC00017352-06 |
NCGC00017352-07 |
NCGC00017352-08 |
NCGC00017352-09 |
NCGC00017352-10 |
NCGC00017352-11 |
NCGC00017352-12 |
NCGC00017352-13 |
NCGC00017352-14 |
NCGC00017352-15 |
NCGC00017352-16 |
NCGC00017352-17 |
NCGC00017352-18 |
NCGC00017352-19 |
NCGC00017352-24 |
NCGC00017352-31 |
NCGC00017352-37 |
NCGC00017352-39 |
NCGC00024003-00 |
NCGC00024003-04 |
NCGC00024003-05 |
NCGC00024003-06 |
NCGC00024003-07 |
NCGC00024003-08 |
NCGC00024003-09 |
NCGC00024003-10 |
NCGC00024003-11 |
NCGC00024003-12 |
NCGC00024003-13 |
NCGC00024003-14 |
NCGC00257465-01 |
NCGC00258925-01 |
NCGC00261796-01 |
1ST40018 |
AS-12413 |
HY-16561 |
CS-0694771 |
EU-0101111 |
R0071 |
Resveratrol, Vetec(TM) reagent grade, 98% |
SW196786-4 |
trans [2,5,4'-trihydroxydiphenyl] ethylene |
C03582 |
N88795 |
5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol |
AB00052942-29 |
AB00052942_31 |
trans-Resveratrol 100 microg/mL in Acetonitrile |
A827984 |
Q407329 |
5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol |
SR-01000000163-3 |
SR-01000000163-4 |
SR-01000000163-9 |
5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol |
5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol |
5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol |
BRD-K25591257-001-01-2 |
BRD-K80738081-001-06-2 |
BRD-K80738081-001-07-0 |
BRD-K80738081-001-09-6 |
BRD-K80738081-001-10-4 |
BRD-K80738081-001-23-7 |
SR-01000000163-10 |
SR-01000000163-11 |
SR-01000000163-16 |
(E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene |
(E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene |
5-((1E)-2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol |
Resveratrol, certified reference material, TraceCERT(R) |
Resveratrol, European Pharmacopoeia (EP) Reference Standard |
1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)-ethenyl)-, (E)- |
533C1DA0-4104-42B5-9D32-9265F40857E4 |
trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard |
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol |
31100-06-8 |
InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1 |